Kyoto, Japan

Hiroya Takahara

This inventor holds 1 USPTO granted patent. Top assignee: Megakaryon Corporation. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroya Takahara. Retrieved from https://idiyas.com/inventor/hiroya-takahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Hiroya Takahara Revolutionizing Platelet Production in Kyoto

Introduction:

Hiroya Takahara, a brilliant inventor based in Kyoto, Japan, has made significant strides in the field of platelet production with his groundbreaking patent.

Latest Patents:

Takahara's patent entails a unique method for producing purified platelets, platelet products, and blood products. This innovative technique involves concentrating a megakaryocyte culture, centrifuging platelets from the concentrate, and washing them with a hollow fiber membrane. The result is the production of purified platelets in a shorter time frame, thereby reducing damage to the platelets.

Career Highlights:

Currently affiliated with Megakaryon Corporation, Hiroya Takahara has been instrumental in advancing the field of platelet research and production. His dedication to innovation and commitment to improving medical processes have garnered recognition from peers and industry experts alike.

Collaborations:

Takahara has collaborated closely with coworkers such as Junko Tomizuka and Haruki Okamoto, pooling their expertise to enhance the efficiency and effectiveness of platelet production methods.

Conclusion:

In conclusion, Hiroya Takahara's pioneering work in platelet production stands as a testament to his ingenuity and dedication to advancing medical technologies. His patent represents a significant contribution to the field, with the potential to revolutionize the way platelets are produced and preserved.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…